ETF Components for FMED - Fidelity Disruptive Medicine ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
BSX A 0.00 6.26
UNH B 0.00 4.70
PODD B 0.00 4.44
ISRG A 0.00 4.42
DHR D 0.00 3.80
ARGX A 0.00 3.27
REGN F 0.00 3.26
ALNY D 0.00 2.90
SYK A 0.00 2.73
EXAS D 0.00 2.72
PEN B 0.00 2.64
LFST C 0.00 2.41
VEEV C 0.00 2.18
MASI B 0.00 2.01
LEGN D 0.00 1.95
EW C 0.00 1.95
INSP F 0.00 1.92
DXCM C 0.00 1.88
TMO D 0.00 1.87
LLY F 0.00 1.78
PRCT B 0.00 1.65
ZLAB C 0.00 1.54
AGL F 0.00 1.43
GKOS A 0.00 1.42
RGEN D 0.00 1.34
PRVA C 0.00 1.34
KROS D 0.00 1.34
JANX C 0.00 1.32
RMD C 0.00 1.30
CRNX B 0.00 1.23
CYTK D 0.00 1.19
XENE D 0.00 1.17
DOCS C 0.00 1.14
DYN D 0.00 1.13
PCVX D 0.00 1.13
BRKR F 0.00 1.12
WST C 0.00 1.01
TNDM D 0.00 1.00
PHR F 0.00 0.99
CNC F 0.00 0.98
ASND F 0.00 0.88
VRTX D 0.00 0.84
ALGN D 0.00 0.72
TXG F 0.00 0.63
NTRA A 0.00 0.56
ACLX C 0.00 0.45
DNLI D 0.00 0.45
NRIX C 0.00 0.44
IRTC C 0.00 0.44
DAWN D 0.00 0.41
BNTX D 0.00 0.40
ANAB F 0.00 0.24

Recent News for Fidelity Disruptive Medicine ETF & its Holdings

Date Stock Title
Nov 21 VEEV Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and Claims
Nov 21 VEEV Veeva on supporting the data burden in the life sciences sector
Nov 20 PODD Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
Nov 20 DAWN Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
Nov 20 PEN Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
Nov 20 IRTC iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
Nov 20 NRIX Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
Nov 20 ALGN Align Technology Has Received CE Mark in Europe for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients
Nov 20 TXG If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer
Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
Nov 20 INSP Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
Nov 20 BRKR Bruker jumps as CEO buys $5M company stock
Nov 20 BRKR Bruker Stock Explodes 10.5% After CEO's $5M Insider Bet
Nov 20 RMD 3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)
Nov 20 INSP Inspire Medical upped to buy by BoA, improved margins cited
Nov 20 UNH Dr. Oz’s CMS Nomination Sparks Mixed Reaction From Healthcare Investors
Nov 20 CNC Dr. Oz’s CMS Nomination Sparks Mixed Reaction From Healthcare Investors
Nov 20 UNH Health insurers spike as Trump picks Dr. Oz to head Medicare
Nov 20 LLY More companies covering weight loss drugs for their employees
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.
Back to the Main FMED Page...